Clinical trial · Observational
Obesity and Liver Function in Oesophageal Cancer
Elucidating the Role of Obesity, Liver Function and Pathology With Overall Outcomes in Oesophageal Cancer
NCT04152044CI-TRIAL-00041455unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
There is an established link between sarcopenia and outcomes in oesophageal cancer. There is scant reports in the literature regarding the influences of different obesity in different compartments.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Function | — | UNRESOLVED | — |
| Obesity | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observation of different types of obesity and liver pathology in patients undergoing and oesophagectomy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Liver biopsy, Visceral and subcutaneous obesity
- description
- Those with histology and LFT's and quantificaiton of obesity
- interventionNames
- Other: Observation of different types of obesity and liver pathology in patients undergoing and oesophagectomy
Primary outcomes (2)
- measure
- Overall Survival
- timeFrame
- 1 year
- measure
- Disease free survival
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Those undergoing oesophagectomy Exclusion Criteria: * patients who only had chemotherapy/chemoradiotherapy without surgery
References
Publications (0)
Data not yet available
No reference posted for this study.